79 related articles for article (PubMed ID: 36246628)
1. Critical role of guanylate binding protein 5 in tumor immune microenvironment and predictive value of immunotherapy response.
Li X; Song D; Su S; He X; Cao F; Yang C; Li K; Huang S; Li C; Wang C; Zhang A; Pang P; Zheng Y
Front Genet; 2022; 13():984615. PubMed ID: 36246628
[No Abstract] [Full Text] [Related]
2. Immunoreactive Microenvironment Modulator GBP5 Suppresses Ovarian Cancer Progression by Inducing Canonical Pyroptosis.
Zou C; Shen J; Xu F; Ye Y; Wu Y; Xu S
J Cancer; 2024; 15(11):3510-3530. PubMed ID: 38817865
[TBL] [Abstract][Full Text] [Related]
3. Evolutionary and functional characterization of lagomorph guanylate-binding proteins: a story of gain and loss and shedding light on expression, localization and innate immunity-related functions.
Schelle L; Côrte-Real JV; Fayyaz S; Del Pozo Ben A; Shnipova M; Petersen M; Lotke R; Menon B; Matzek D; Pfaff L; Pinheiro A; Marques JP; Melo-Ferreira J; Popper B; Esteves PJ; Sauter D; Abrantes J; Baldauf HM
Front Immunol; 2024; 15():1303089. PubMed ID: 38348040
[TBL] [Abstract][Full Text] [Related]
4. Pan-Cancer Analysis and Validation of Opioid-Related Receptors Reveals the Immunotherapeutic Value of Toll-Like Receptor 4.
Wu S; Chen J; Huang E; Zhang Y
Int J Gen Med; 2023; 16():5527-5548. PubMed ID: 38034898
[TBL] [Abstract][Full Text] [Related]
5. Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac
Jin C; Wang T; Zhang D; Yang P; Zhang C; Peng W; Jin K; Wang L; Zhou J; Peng C; Tan Y; Ji J; Chen Z; Sun Q; Yang S; Tang J; Feng Y; Sun Y
J Exp Clin Cancer Res; 2022 Dec; 41(1):345. PubMed ID: 36522719
[TBL] [Abstract][Full Text] [Related]
6. GBP5 Identifies Immuno-Hot Tumors and Predicts the Therapeutic Response to Immunotherapy in NSCLC.
Fan H; Shi Y; Wang H; Li Y; Mei J; Xu J; Liu C
Int J Gen Med; 2023; 16():1757-1769. PubMed ID: 37193249
[TBL] [Abstract][Full Text] [Related]
7. Guanylate binding protein 5 accelerates gastric cancer progression via the
Cao FY; Wang CH; Li X; Ma MZ; Tao GC; Yang C; Li K; He XB; Tong SL; Zhao QC; Su S; Song D; Zheng YB
Am J Cancer Res; 2023; 13(4):1310-1328. PubMed ID: 37168340
[TBL] [Abstract][Full Text] [Related]
8. Exosomal circCOL1A2 from cancer cells accelerates colorectal cancer progression via regulating miR-665/LASP1 signal axis.
Miao Z; Zhao X; Liu X
Eur J Pharmacol; 2023 Jul; 950():175722. PubMed ID: 37059374
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer.
Pang L; Wang Q; Wang L; Hu Z; Yang C; Li Y; Wang Z; Li Y
BMC Med Genomics; 2023 Mar; 16(1):58. PubMed ID: 36949429
[TBL] [Abstract][Full Text] [Related]
10. Anti-colon cancer effects of Spirulina polysaccharide and its mechanism based on 3D models.
Lu Y; Chen Z; Lin Q; Xia X; Lin Y; Yan J; Huang M; Huang R
Int J Biol Macromol; 2023 Feb; 228():559-569. PubMed ID: 36581031
[TBL] [Abstract][Full Text] [Related]
11. Identification of KIF21B as a Biomarker for Colorectal Cancer and Associated with Poor Prognosis.
Xu S; Li Y; Huang H; Miao X; Gu Y
J Oncol; 2022; 2022():7905787. PubMed ID: 36451772
[TBL] [Abstract][Full Text] [Related]
12. GBP3-STING interaction in glioblastoma coordinates autophagy, anti-oxidative, and DNA repair programs in response to temozolomide.
Ma J; Wang Z; Chen CC; Li M
Oncotarget; 2023 May; 14():483-484. PubMed ID: 37204260
[No Abstract] [Full Text] [Related]
13. Cancer-Associated Fibroblast Risk Model for Prediction of Colorectal Carcinoma Prognosis and Therapeutic Responses.
Wang Y; Chen Z; Zhao G; Li Q
Mediators Inflamm; 2023; 2023():3781091. PubMed ID: 37144239
[TBL] [Abstract][Full Text] [Related]
14. Targeted EpCAM-binding for the development of potent and effective anticancer proteins.
Liu Z; Zhang C; Cui B; Wang Y; Lim K; Li K; Thiery JP; Chen J; Ho CL
Biomed Pharmacother; 2023 May; 161():114443. PubMed ID: 36863098
[TBL] [Abstract][Full Text] [Related]
15. Site-directed late-stage diversification of macrocyclic nannocystins facilitating anticancer SAR and mode of action studies.
Zhang H; Tian Y; Yuan X; Xie F; Yu S; Cai J; Sun B; Shan C; Zhang W
RSC Med Chem; 2023 Feb; 14(2):299-312. PubMed ID: 36846368
[TBL] [Abstract][Full Text] [Related]
16. The Upregulation of GSTO2 is Associated with Colon Cancer Progression and a Poor Prognosis.
Peng X; Zhu J; Liu S; Liu Z; Luo C; Wu X; Yu Z; Zhu Z
J Oncol; 2023; 2023():4931650. PubMed ID: 36688005
[TBL] [Abstract][Full Text] [Related]
17. Identification of a tissue resident memory CD8 T cell-related risk score signature for colorectal cancer, the association with TME landscapes and therapeutic responses.
Li J; Yang C; Zheng Y
Front Genet; 2022; 13():1088230. PubMed ID: 36685946
[No Abstract] [Full Text] [Related]
18. Investigation of the Effects of Glabridin on the Proliferation, Apoptosis, and Migration of the Human Colon Cancer Cell Lines SW480 and SW620 and Its Mechanism Based on Reverse Virtual Screening and Proteomics.
Li T; Li H; Xia W; Li M; Niu Y; Fu X
Oxid Med Cell Longev; 2023; 2023():1117431. PubMed ID: 36644579
[TBL] [Abstract][Full Text] [Related]
19. Identifying the key genes of Epstein-Barr virus-regulated tumour immune microenvironment of gastric carcinomas.
Zhou H; Jing S; Liu Y; Wang X; Duan X; Xiong W; Li R; Peng Y; Ai Y; Fu D; Wang H; Zhu Y; Zeng Z; He Y; Ye Q
Cell Prolif; 2023 Mar; 56(3):e13373. PubMed ID: 36519208
[TBL] [Abstract][Full Text] [Related]
20. Genetic Variants as Predictors of the Success of Colorectal Cancer Treatments.
Garcia-Etxebarria K; Etxart A; Barrero M; Nafria B; Segues Merino NM; Romero-Garmendia I; Goel A; Franke A; D'Amato M; Bujanda L
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
